- Trials with a EudraCT protocol (98)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
98 result(s) found for: Phase Angle.
Displaying page 1 of 5.
EudraCT Number: 2010-022586-10 | Sponsor Protocol Number: SCO 5511 | Start Date*: 2011-05-05 | |||||||||||
Sponsor Name:Alfred E. Tiefenbacher (GmbH & Co. KG) | |||||||||||||
Full Title: Randomized, Double-Masked, Active Controlled, Crossover Phase III Equivalence Study of Travoprost Eye Drops Solution in Subjects with Open Angle Glaucoma or Ocular Hypertension | |||||||||||||
Medical condition: Open Angle Glaucoma or Ocular Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-009182-34 | Sponsor Protocol Number: DOR/2008 | Start Date*: 2009-03-30 | |||||||||||
Sponsor Name:ALFRED E. TIEFENBACHER (GMBH & CO. KG) | |||||||||||||
Full Title: RANDOMIZED, DOUBLE MASKED; ACTIVE CONTROLLED, CROSSOVER PHASE III EQUIVALENCE STUDY OF DORZOLAMIDE 2 % EYE DROPS SOLUTION IN SUBJECTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION | |||||||||||||
Medical condition: Open angle glaucoma or ocular hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000044-10 | Sponsor Protocol Number: QTM/OMN0114 | Start Date*: 2015-03-30 | ||||||||||||||||
Sponsor Name:OMNIVISION | ||||||||||||||||||
Full Title: Open, Observer-blind, two Parallel Group, Randomized, Multicentric Clinical Phase III Trial on the Comparison of Efficacy and Tolerability of a New Preservative-free Formulation of the Fixed Combin... | ||||||||||||||||||
Medical condition: Open Angle Glaucoma or Ocular Hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-003083-31 | Sponsor Protocol Number: Becro/OV/Brimo | Start Date*: 2013-10-17 | ||||||||||||||||
Sponsor Name:OmniVision GmbH | ||||||||||||||||||
Full Title: Open, Observer-blind, two Parallel Group, Randomized, Multicentric Clinical Phase III Trial on the Comparison of Efficacy and Tolerability of a New Preservative-free Formulation of Brimonidine 2 mg... | ||||||||||||||||||
Medical condition: Open angle glaucoma or ocular hypertension. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-002501-45 | Sponsor Protocol Number: EMD-06-02 | Start Date*: 2008-03-14 | ||||||||||||||||
Sponsor Name:Alcon Laboratories Inc. | ||||||||||||||||||
Full Title: Phase IV randomised double masked clinical trial: Assessing morning versus evening dosing of a fixed dose combination of Travoprost 0.004% / Timolol Maleate 0.5% in patients with primary open angle... | ||||||||||||||||||
Medical condition: Open - angle glaucoma or ocular hypertension. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022984-36 | Sponsor Protocol Number: 201051 | Start Date*: Information not available in EudraCT | ||||||||||||||||||||||||||
Sponsor Name:Santen Oy | ||||||||||||||||||||||||||||
Full Title: A phase III, randomized, double-masked 6-month clinical study to compare the efficacy and safety of the preservative-free fixed dose combination of tafluprost 0.0015% and timolol 0.5% eye drops to ... | ||||||||||||||||||||||||||||
Medical condition: Patients diagnosed with ocular hypertension or open-angle glaucoma (primary open-angle glaucoma [POAG], capsular glaucoma or pigmentary glaucoma). | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: HU (Completed) LV (Completed) CZ (Completed) ES (Completed) PT (Completed) AT (Completed) BG (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-020746-98 | Sponsor Protocol Number: 77557 | Start Date*: 2010-11-01 | ||||||||||||||||
Sponsor Name:Santen Oy | ||||||||||||||||||
Full Title: An open-label phase IV study on the changes in ocular signs and symptoms in patients with ocular hypertension or open-angle glaucoma switched from preserved travoprost 0.004% eye drops to preservat... | ||||||||||||||||||
Medical condition: Patients diagnosed with Ocular Hypertension or Open-angle glaucoma (primary open-angle glaucoma [POAG] or capsular glaucoma) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-021039-14 | Sponsor Protocol Number: S001-2010 | Start Date*: 2010-08-19 | ||||||||||||||||
Sponsor Name:Tampere University, Faculty of Medicine, Department of Ophthalmology | ||||||||||||||||||
Full Title: An open-label, phase IV, pilot study, to evaluate confocal microscopic findings of cornea, ocular signs and symptoms in patients with ocular hypertension or open-angle glaucoma switching from latan... | ||||||||||||||||||
Medical condition: Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG); primary open-angle glaucoma [POAG] or capsular glaucoma. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005273-37 | Sponsor Protocol Number: 201450 | Start Date*: 2015-02-17 | |||||||||||||||||||||
Sponsor Name:Santen Oy | |||||||||||||||||||||||
Full Title: A phase IV study on the changes in ocular signs and symptoms in patients with ocular hypertension or open-angle glaucoma switched from Ganfort® eye drops (bimatoprost 0.03%/timolol 0.5%) to Taptiq... | |||||||||||||||||||||||
Medical condition: Glaucoma or Ocular Hypertension | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FI (Completed) DE (Completed) IT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022965-82 | Sponsor Protocol Number: 201050 | Start Date*: 2010-12-22 | ||||||||||||||||||||||||||
Sponsor Name:Santen Oy | ||||||||||||||||||||||||||||
Full Title: A phase III, randomized, double-masked 6-month clinical study to compare the efficacy and safety of the preservative-free fixed-dose combination of tafluprost 0.0015% and timolol 0.5% eye drops to ... | ||||||||||||||||||||||||||||
Medical condition: Ocular hypertension and POAG, capsular glaucoma and pigmentary glaucoma | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FI (Completed) GB (Completed) DE (Completed) EE (Completed) NL (Completed) PL (Completed) IT (Completed) BE (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-000395-15 | Sponsor Protocol Number: MATR1001 | Start Date*: 2016-03-10 | |||||||||||
Sponsor Name:Moorfields Eye Hospital NHS Foundation Trust | |||||||||||||
Full Title: The use of bevacizumab as a modulator of wound healing following trabeculectomy surgery: A Single Centre Randomised Controlled Phase III Pilot Study. | |||||||||||||
Medical condition: Primary Open Angle Glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002574-52 | Sponsor Protocol Number: 1698-301-007 | Start Date*: 2019-08-01 | ||||||||||||||||
Sponsor Name:Allergan Ltd. | ||||||||||||||||||
Full Title: A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension | ||||||||||||||||||
Medical condition: Open-Angle Glaucoma or Ocular Hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Trial now transitioned) IE (Trial now transitioned) SE (Completed) CZ (Trial now transitioned) HU (Ongoing) PL (Trial now transitioned) DK (Trial now transitioned) BG (Ongoing) IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004262-95 | Sponsor Protocol Number: 0130A01SA | Start Date*: 2019-01-07 | ||||||||||||||||
Sponsor Name:Santen SAS | ||||||||||||||||||
Full Title: Phase III, Multinational, Multicenter, Investigator-Masked, Randomised, Active-Controlled Trial, comparing the efficacy and safety of DE-130A with Xalatan® in Patients with Open-Angle Glaucoma or O... | ||||||||||||||||||
Medical condition: Open-Angle Glaucoma or Ocular Hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) GB (GB - no longer in EU/EEA) DE (Completed) EE (Completed) PL (Completed) ES (Completed) BE (Completed) AT (Completed) LV (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-003597-26 | Sponsor Protocol Number: 1698-302-007 | Start Date*: 2019-11-07 | ||||||||||||||||
Sponsor Name:Allergan Ltd. | ||||||||||||||||||
Full Title: An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension | ||||||||||||||||||
Medical condition: Open-angle Glaucoma and Ocular Hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DK (Completed) AT (Prematurely Ended) DE (Ongoing) BE (Completed) ES (Ongoing) IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002895-42 | Sponsor Protocol Number: GITS2013_4.0 | Start Date*: 2013-10-10 | ||||||||||||||||
Sponsor Name:Region Västerbotten | ||||||||||||||||||
Full Title: Glaucoma Intensity Treatment Study – Intensive non-invasive glaucoma treatment vs conventional stepwise treatment – a prospective, randomized phase IV study of disease progression in glaucoma (GITS... | ||||||||||||||||||
Medical condition: Glaucoma, open-angle and PEX glaucoma. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001727-39 | Sponsor Protocol Number: POP03 | Start Date*: 2018-10-16 | ||||||||||||||||
Sponsor Name:Polpharma S.A. | ||||||||||||||||||
Full Title: A PHASE III, MULTICENTRE, RANDOMISED, INVESTIGATOR-MASKED, CROSSOVER, COMPARATIVE, NON-INFERIORITY TRIAL EVALUATING THE EFFICACY AND TOLERABILITY OF GENERIC LATANOPROST 0.05 MG/ML EYE DROPS SOLUTIO... | ||||||||||||||||||
Medical condition: Ocular hypertension and open angle glaucoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-003387-27 | Sponsor Protocol Number: 848300145/0129/1POP04 | Start Date*: 2021-11-02 | ||||||||||||||||
Sponsor Name:Pharmaceutical Works Polpharma S.A. (Polpharma S. A.) | ||||||||||||||||||
Full Title: A PHASE III, MULTICENTRE, RANDOMISED, INVESTIGATOR-MASKED, CROSS-OVER, COMPARATIVE, NON-INFERIORITY TRIAL OF GENERIC LATANOPROST + TIMOLOL (50μG + 5MG)/ML EYE DROPS, SOLUTION (POLPHARMA S.A.) COMPA... | ||||||||||||||||||
Medical condition: Ocular hypertension and open angle glaucoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003089-42 | Sponsor Protocol Number: OPHT-250719 | Start Date*: 2019-12-23 | |||||||||||
Sponsor Name:Medical University of Vienna, Department of Clinical Pharmacology | |||||||||||||
Full Title: The effect of Tetrahydrocannabinol on ocular hemodynamics in patients with primary open angle glaucoma- A Phase II Study | |||||||||||||
Medical condition: The study will be carried out in patients with primary open angle glaucoma and healthy subjects | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015798-11 | Sponsor Protocol Number: 2452-001 | Start Date*: 2010-03-25 | ||||||||||||||||
Sponsor Name:Merck & Co., Inc. | ||||||||||||||||||
Full Title: Ensayo de fase III, aleatorizado, controlado con un fármaco de comparación activo, con doble enmascaramiento, de doce semanas de duración, para comparar la eficacia y la seguridad de MK-2452 (0,00... | ||||||||||||||||||
Medical condition: Glaucoma de ángulo abierto e hipertensión ocular /Open-Angle Glaucoma and Ocular Hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-000026-22 | Sponsor Protocol Number: QTM/OMN0112 | Start Date*: 2012-07-23 | ||||||||||||||||
Sponsor Name:Omnivision GmbH | ||||||||||||||||||
Full Title: Open, Observer-blind, two Parallel Group, Randomized, Multicentric Clinical Phase III Trial on the Comparison of Efficacy and Tolerability of a New Preservative-free Formulation of Travoprost 40 µg... | ||||||||||||||||||
Medical condition: Primary open angle glaucoma or intraocular hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.